v3.25.2
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net loss $ (13,446) $ (11,395)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 204 199
Stock-based compensation 741 736
Non-cash lease expense 114 155
Fixed assets write-off 34
Changes in operating assets and liabilities:    
R&D tax credit incentive receivable (241)
Prepaid expenses and other assets 412 1,004
Accounts payable 933 107
Accrued compensation expenses 13 (12)
Accrued expenses 20 (141)
Net cash used in operating activities (11,250) (9,313)
Cash flows from investing activities:    
Purchases of property and equipment (76) (219)
Net cash used in investing activities (76) (219)
Cash flows from financing activities:    
Issuance of common stock and warrants in connection with securities purchase agreement, net of issuance costs 13,687
Issuance of common stock and warrants in connection with the Sales Agreement, net of issuance costs 112
Net issuance costs in connection with the Sales Agreement (28)
Principal payment for insurance premium loan (237)
Net cash (used in) provided by financing activities (265) 13,799
Effect of exchange rate changes on cash and cash equivalents 33 (2)
Net (decrease) increase in cash, cash equivalents and restricted cash (11,558) 4,265
Cash, cash equivalents and restricted cash balance at beginning of period 19,690 21,992
Cash, cash equivalents and restricted cash balance at end of period 8,132 26,257
Cash paid during the period for:    
Income taxes 2 2
Non-cash investing and financing activities:    
Purchases of property and equipment in accounts payable and accrued expenses $ 12 $ (5)

Source

PDF HTML
ZIP XLS XBRL